Yaqi Zhao

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults”.

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

New England Journal of Medicine(2024)10.1056/nejmoa2312948

N/A

4.4DataRank · unranked

227 citations

Zhuoxin Sun, Ryan J. Mattison, Elisabeth Paietta, Kathryn G. Roberts, Yanming Zhang +37 more

Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL

Blood(2020)10.1182/blood.2020006287

N/A

0DataRank · unranked

172 citations

Ibrahim Aldoss, Chunxu Qu, Jeremy Chase Crawford, Zhaohui Gu, E. Kaitlynn Allen +14 more

NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia

Nature Immunology(2022)10.1038/s41590-022-01314-y

N/A

0DataRank · unranked

59 citations

Soobeom Lee, Eric Wang, Anna K. Lee, Alexis Talbot, Chao Ma +15 more

Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia

Blood(2022)10.1182/blood.2022015444

N/A

0DataRank · unranked

51 citations

Lindsey E. Montefiori, Ilaria Iacobucci, Yaqi Zhao, Qingsong Gao, Elisabeth Paietta +31 more

Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL

medRxiv(2023)10.1101/2023.12.06.23299616

N/A

0DataRank · unranked

1 citations

Nicholas J. Short, Hagop M. Kantarjian, Ti‐Cheng Chang, Pankaj S. Ghate, Chunxu Qu +17 more